1 September 2017 EMA/578102/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance(s): tibolone

Procedure No.: PSUSA/00002947/201612

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

Boltin 2,5 mg comprimidos

not available

60.100

Boltin 2,5 mg comprimidos LIVIAL 2,5 mg compresse Livial 2,5 mg comprimidos Livial 2,5 mg comprimidos Livial 2,5 mg tablete Livial 2,5 mg tablete Livial 2,5 mg tabletes Livial 2,5 mg tabletės Livial 2,5 mg tablett Livial 2,5 mg tabletta Livial 2,5 mg tabletta Livial 2,5 mg tabletter Livial 2,5 mg tabletter Livial 2,5 mg tabletti Livial 2,5 mg töflur Livial 2,5 mg δισκία LIVIAL 2,5 mg, comprimé LIVIAL 2,5 mg, comprimé LIVIAL 2,5 mg, comprimé LIVIAL 2,5 mg, comprimé Livial 2,5 mg, tablety Livial 2.5 mg tablets Livial 2.5 mg tablets LIVIAL 2.5mg Tablets Livial, 2,5 mg tabletid Livial, 2,5 mg tabletten Livial, 2,5 mg, tabletki Livial, tabletter Livial, tabletter Livial® 2,5 mg comprimés Livial® 2,5 mg tabletten Livial® 2.5 mg tablets LIVIAL® 2,5 mg tablety

not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available not available

60.100 028035018 8777318 8777300 H/98/00931/001 H/98/00931/001 98-0299 LT/1/98/2570/001 11701 OGYI-T-20953/01 OGYI-T-20953/02 95-3901 13115 11701 950170 43544/18-09-2009 354 358-6 360 942-8 354 359-2 360 943-4 54/0249/91-C/S 13428 MA058/03201 PA 0964/006/001 275599 RVG 11146 R/1580 12136 12136 2011041112 BE158593 PL 00025/0599

MERCK SHARP & DOHME DE ESPAÑA, S.A MERCK SHARP & DOHME DE ESPAÑA, S.A NV ORGANON MERCK SHARP & DOHME, LDA. MERCK SHARP & DOHME, LDA. NV ORGANON NV ORGANON NV ORGANON NV ORGANON MERCK SHARP & DOHME BV MSD PHARMA HUNGARY KFT. MSD PHARMA HUNGARY KFT. MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV MSD GREECE MSD FRANCE MSD FRANCE MSD FRANCE MSD FRANCE NV ORGANON NV ORGANON MERCK SHARP & DOHME LTD. NV ORGANON NV ORGANON NV ORGANON NV ORGANON MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV MSD BELGIUM BVBA/SPRL MSD BELGIUM BVBA/SPRL MERCK SHARP & DOHME LTD.

not available

54/249/91-C

NV ORGANON

List of nationally authorised medicinal products EMA/578102/2017

MAH of product in the member state

Member State where product is authorised

ES ES IT PT PT SI SI LV LT FI HU HU NO SE FI IS GR FR FR FR FR SK CY MT IE EE NL PL DK DK LU BE UK CZ Page 2/3

Product Name (in authorisation country)

LIVIAL® 2,5 mg tablety

Liviel – Tabletten Liviella 2,5 mg Tabletten Tibolon, 2,5 mg tabletten Ливиал 2,5 mg таблетки

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

not available

54/249/91-C

CZ

not available

1-20657

NV ORGANON MERCK SHARP & DOHME GES.M.B.H.

not available not available not available

33692.00.00 RVG 11146 20000198

MSD SHARP & DOHME GMBH NV ORGANON NV ORGANON

DE NL BG

List of nationally authorised medicinal products EMA/578102/2017

AT

Page 3/3

PSUSA/00002947/201612 - European Medicines Agency - Europa EU

Sep 1, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website www.ema.europa.eu/contact. © European ...

149KB Sizes 36 Downloads 134 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...